Display options
Share it on

Int J Hypertens. 2018 Jun 19;2018:4701097. doi: 10.1155/2018/4701097. eCollection 2018.

Predictors of Noncompliance to Antihypertensive Therapy among Hypertensive Patients Ghana: Application of Health Belief Model.

International journal of hypertension

Yaa Obirikorang, Christian Obirikorang, Emmanuel Acheampong, Enoch Odame Anto, Daniel Gyamfi, Selorm Philip Segbefia, Michael Opoku Boateng, Dari Pascal Dapilla, Peter Kojo Brenya, Bright Amankwaa, Evans Asamoah Adu, Emmanuel Nsenbah Batu, Adjei Gyimah Akwasi, Beatrice Amoah

Affiliations

  1. Department of Nursing, Faculty of Health and Allied Sciences, Garden City University College (GCUC), Kenyasi, Kumasi, Ghana.
  2. Department of Molecular Medicine, School of Medical Science, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
  3. School of Medical and Health Science, Edith Cowan University, Joondalup, Australia.
  4. Department of Medical Laboratory Technology, Faculty of Allied Health Sciences, KNUST, Ghana.
  5. Department of Nursing, Kintampo Municipal Hospital, Kintampo, Ghana.
  6. Department of Community Health, School of Medical Sciences, KNUST, Ghana.

PMID: 30018819 PMCID: PMC6029446 DOI: 10.1155/2018/4701097

Abstract

This study determined noncompliance to antihypertensive therapy (AHT) and its associated factors in a Ghanaian population by using the health belief model (HBM). This descriptive cross-sectional study conducted at Kintampo Municipality in Ghana recruited a total of 678 hypertensive patients. The questionnaire constituted information regarding sociodemographics, a five-Likert type HBM questionnaire, and lifestyle-related factors. The rate of noncompliance to AHT in this study was 58.6%. The mean age (SD) of the participants was 43.5 (±5.2) years and median duration of hypertension was 2 years. Overall, the five HBM constructs explained 31.7% of the variance in noncompliance to AHT with a prediction accuracy of 77.5%, after adjusting for age, gender, and duration of condition. Higher levels of perceived benefits of using medicine [aOR=0.55(0.36-0.82),p=0.0001] and cue to actions [aOR=0.59(0.38-0.90),p=0.0008] were significantly associated with reduced noncompliance while perceived susceptibility [aOR=3.05(2.20-6.25), p<0.0001], perceived barrier [aOR=2.14(1.56-2.92), p<0.0001], and perceived severity [aOR=4.20(2.93-6.00),p<0.0001] were significantly associated with increased noncompliance to AHT. Participant who had completed tertiary education [aOR=0.27(0.17-0.43), p<0.0001] and had regular source of income [aOR=0.52(0.38-0.71), p<0.0001] were less likely to be noncompliant. However, being a government employee [aOR=4.16(1.93-8.96), p=0.0002)] was significantly associated increased noncompliance to AHT. Noncompliance to AHT was considerably high and HBM is generally reliable in assessing treatment noncompliance in the Ghanaian hypertensive patients. The significant predictors of noncompliance to AHT were higher level of perceived barriers, susceptibility, and severity. Intervention programmes could be guided by the association of risk factors, HBM constructs with noncompliance to AHT in clinical practice.

References

  1. Cardiovasc Diagn Ther. 2016 Feb;6(1):67-77 - PubMed
  2. J Clin Pharm Ther. 2004 Oct;29(5):417-24 - PubMed
  3. Aliment Pharmacol Ther. 2005 May 15;21(10):1255-62 - PubMed
  4. Zhonghua Liu Xing Bing Xue Za Zhi. 2001 Dec;22(6):418-20 - PubMed
  5. Eur Respir J. 2004 Sep;24(3):461-5 - PubMed
  6. J Adv Nurs. 1999 Apr;29(4):832-9 - PubMed
  7. Exp Clin Transplant. 2003 Jun;1(1):39-47 - PubMed
  8. J Pharm Pharm Sci. 2004 Nov 12;7(3):350-2 - PubMed
  9. Health Commun. 2010 Dec;25(8):661-9 - PubMed
  10. Ghana Med J. 2012 Jun;46(2 Suppl):4-11 - PubMed
  11. BMC Complement Altern Med. 2014 Feb 04;14:44 - PubMed
  12. Cardiovasc Drugs Ther. 2004 Nov;18(6):475-81 - PubMed
  13. Int J Hypertens. 2016;2016:3292938 - PubMed
  14. BMC Res Notes. 2012 Oct 24;5:579 - PubMed
  15. Int J Gen Med. 2014 Jul 03;7:345-53 - PubMed
  16. J Cardiovasc Nurs. 2016 Jul-Aug;31(4):296-303 - PubMed
  17. Patient Educ Couns. 2016 Nov;99(11):1894-1900 - PubMed
  18. Transplant Proc. 2004 Jan-Feb;36(1):120-1 - PubMed
  19. PLoS One. 2007 Mar 14;2(3):e280 - PubMed
  20. Curationis. 2004 Aug;27(3):15-23 - PubMed
  21. Diabet Med. 2009 Jan;26(1):5-13 - PubMed
  22. Eur Respir J. 2008 Sep;32(3):710-7 - PubMed
  23. Health Educ Q. 1984 Spring;11(1):1-47 - PubMed
  24. J Ayub Med Coll Abbottabad. 2015 Jan-Mar;27(1):158-63 - PubMed
  25. BMC Public Health. 2010 Jul 14;10:418 - PubMed
  26. BMC Womens Health. 2009 Dec 29;9:37 - PubMed
  27. J Ayub Med Coll Abbottabad. 2008 Apr-Jun;20(2):66-9 - PubMed
  28. Ann Med Health Sci Res. 2014 Nov;4(6):922-7 - PubMed
  29. Int J Hypertens. 2015;2015:205716 - PubMed
  30. Curationis. 2010 Jun;33(2):33-40 - PubMed
  31. J Clin Hypertens (Greenwich). 2012 Dec;14(12):877-86 - PubMed
  32. Am J Hypertens. 1995 Oct;8(10 Pt 2):82S-88S - PubMed
  33. Eur J Clin Pharmacol. 2001 Oct;57(8):589-94 - PubMed
  34. JAMA. 2002 Dec 11;288(22):2880-3 - PubMed
  35. Patient Educ Couns. 2015 May;98(5):669-73 - PubMed
  36. Eur J Cardiovasc Prev Rehabil. 2005 Jun;12(3):243-9 - PubMed
  37. J Pharm Bioallied Sci. 2014 Apr;6(2):104-8 - PubMed

Publication Types